Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00181948
First received: September 13, 2005
Last updated: June 18, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)